Health Canada approves RetinaLogik’s VR visual exam platform
RetinaLogik has secured Class II medical device approval from Health Canada for its visual field exam platform. Coming in the form …
Post
-
-
Researchers at UCalgary to use nuclear imaging for adrenal disorder treatment
Researchers at the University of Calgary (UCalgary) in Canada are set to make use of nuclear adrenal imaging, specifically a …
-
Laplace raises funding to complete study of tricuspid valve technology
US medical device company Laplace Interventional has completed a Series C financing round to support the completion of an early …
-
Cybersecurity in healthcare: getting the basics right as bigger threats loom
The healthcare industry is second only to finance in the volume of sensitive data held. Therefore, the onus is on medical …
-
C2N Diagnostics lands $10m cash injection from Samsung
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said the cash …
-
Vave Health launches Universal Wireless Probe for full-body imaging
Vave Health has launched Universal Wireless Probe, a handheld device aimed at improving accuracy, diagnostics and efficiency in various clinical …
-
Helius joins BCI landscape with new subsidiary
Helius Medical Technologies is muscling in on the promising brain computer interface (BCI) field with the launch of a new …
-
Roche Diagnostics supports UK eye cancer AI initiative
Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a …
-
University of Turku develops carbon nanotube sensors for health monitoring
Researchers at Finland’s University of Turku have developed sensors from single-wall carbon nanotubes, which may be suited for continuous health …
-
FDA approves early feasibility study of Valcare’s transcatheter device
The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption application, allowing it to …
-
Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the …
-
FDA clears Perfuze’s Zipline access catheter for stroke treatment
The US Food and Drug Administration (FDA) has cleared Perfuze’s Zipline single-use access catheter for acute ischemic stroke (AIS) procedures. The …
-
Proteomics announces Australian launch of predictive diabetic kidney test
Proteomics International Laboratories has launched the PromarkerD diabetic kidney disease (DKD) predictive test in Australia. The test is said to predict …
-
MicroTransponder receives $65m to advance stroke care with Vivistim
MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the …
-
Nearly a third of FDA medical device adverse event reports filed late
Almost a third of medical device adverse events (AEs) were reported by manufacturers later than the US Food and Drug …
